Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.
Thompson EM, Landi D, Brown MC, Friedman HS, McLendon R, Herndon JE 2nd, Buckley E, Bolognesi DP, Lipp E, Schroeder K, Becher OJ, Friedman AH, McKay Z, Walter A, Threatt S, Jaggers D, Desjardins A, Gromeier M, Bigner DD, Ashley DM.
Post-poliomyelitis syndrome as a possible viral disease.
Baj A, Colombo M, Headley JL, McFarlane JR, Liethof MA, Toniolo A.
Int J Infect Dis. 2015 Jun;35:107-16. doi: 10.1016/j.ijid.2015.04.018. Epub 2015 May 1.
PMID:25939306
Guidelines on vaccinations in paediatric haematology and oncology patients.
Cesaro S, Giacchino M, Fioredda F, Barone A, Battisti L, Bezzio S, Frenos S, De Santis R, Livadiotti S, Marinello S, Zanazzo AG, Caselli D.
Biomed Res Int. 2014;2014:707691. doi: 10.1155/2014/707691. Epub 2014 Apr 29.
PMID:24868544
Risk factors for post-polio syndrome among an Italian population: a case-control study.
Bertolasi L, Acler M, dall'Ora E, Gajofatto A, Frasson E, Tocco P, Turri M, Ferlisi M, Fiorini M, Pimazzoni F, Squintani G, Martini M, Danzi B, Monaco S.
Neurol Sci. 2012 Dec;33(6):1271-5. doi: 10.1007/s10072-012-0931-2. Epub 2012 Jan 14.
PMID:22246456
Treatment of poliomyelitis in the recovery and residual phases.
McCARROLL HR.
Mo Med. 1947 Dec;44(12):888-91.
PMID:18897697
Patients with post-polio syndrome are more likely to have subclinical involvement as compared to polio survivors without new symptoms.
On AY, Sungur U.
Ann Indian Acad Neurol. 2016 Jan-Mar;19(1):44-7. doi: 10.4103/0972-2327.167705.